Latest Breaking News On - Jonathan barratt - Page 7 : comparemela.com

Examining eGFR Slopes and Changes in Proteinuria in IgA Nephropathy, with Jonathan Barratt, MD

Joanthan Barratt, MD, discusses the results of a RaDaR analysis aimed at examining trends in time-averaged proteinuria and eGFR slope in patients with IgA nephropathy.

United statesUnited kingdomJonathan barrattAmerican society of nephrology kidney weekAlnylam pharmaceuticalsUnited kingdom kidney associationUniversity of leicesterAmerican societyNephrology kidney weekUnited kingdom national registryRare kidney diseasesMayer professorRenal medicineCalliditas therapeuticsTravere therapeuticsChinook therapeutics

Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis

Preliminary data from the open-label RUBY-3 trial were presented at the American Society of Nephrology Kidney Week 2023.

United statesEmory university school of medicineJames tumlinJonathan barrattAmerican society of nephrology kidney weekUniversity of leicesterAlpine immune sciencesNephronet clinical trials consortiumGeorgia nephrologyAmerican societyNephrology kidney weekEmory university schoolNephronet clinical trialsKidney weekImmune sciencesMayer professor

Budesonide Reduces eGFR Decline, Effect Could Prevent Clinical Events in IgA Nephropathy

Data for a pair of studies presented at Kidney Week 2023 provide an overview of the effects of eGFR and how this might translate to potential long-term benefit in patients IgA nephropathy.

United statesRichard lafayetteJonathan barrattUniversity of leicesterStanford glomerular disease centerAlnylam pharmaceuticalsAmerican society of nephrology kidney weekAmerican societyNephrology kidney weekIgard studyKidney weekMayer professorRenal medicineLeicester generalCalliditas therapeuticsTravere therapeutics

Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session at the American Society of Nephrology Kidney Week 2023

Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session at the American Society of Nephrology Kidney Week 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan barrattJames tumlinAlpine immune sciences incUniversity of leicesterNephronet clinical trials consortiumAlpine immune sciencesExchange commissionPennsylvania convention centerAmerican society of nephrologySecurities exchangeAmerican societyKidney weekMeaningful improvementsSuggesting remissionBusiness wire

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (2)

STOCKHOLM, Oct. 19, 2023 /PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX).

United statesStanford healthcaredateRichard philipsonHong zhangdateThierry christophedateNadia nawazRoisin thomasdateJonathan barrattRichard lafayetteAmerican society of nephrologyUniversity of leicesterdateExhibit hallsbd pennsylvania convention centerPennsylvania convention centerAmerican societyKidney weekPrimary iga